Android app Apple app link

Reveal Genomics and Ona link on ONA-255 development for cancer

By Yahoo! Finance   |   3 weeks ago
Reveal Genomics and Ona link on ONA-255 development for cancer

Reveal Genomics and Ona Therapeutics partner to accelerate the clinical development of ONA-255, an antibody-drug conjugate targeting common solid tumors. Dr. Aleix Prat leads the collaboration, focusing on biomarker analysis to enhance therapy efficacy.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.